[ad_1]
No country in the world has administered as many initial doses of vaccine per capita as Israel. Currently, more than 4.9 million Israelis have received their first dose and 3.6 million the second of the Pfizer vaccine, out of the country’s nine million people, reports the Jerusalem Post.
The country is also functioning as a living laboratory since Prime Minister Benjamin Netanyahu signed an agreement with Pfizer to share data in exchange for 10 million doses of the vaccine. This is information on side effects and protective effect in different population groups, says Politico.
Now presents Israel The Ministry of Health reported suspected side effects of the Pfizer vaccine.
A total of 9,595 of 4,755,585 people reported adverse reactions after the first dose. The figure after the second dose is 8,743 out of 3,408,825. Most are women and young people between the ages of 20 and 49.
Most symptoms are quite mild and often involve reactions near the injection site. According to the Ministry of Health report, only 153 out of more than 4.7 million people are suspected of having suffered some kind of serious side effects after the first injection. The figure after the other is 162 out of 3.4 million. These include blurred vision, heart inflammation, liver damage, or heart attack.
After the first dose, 62 people were hospitalized, but three-quarters of them already had underlying medical conditions before vaccination. 42 people were hospitalized after the second dose.
487 people reported neurological disorders after the first injection and 250 after the second. 474 experienced paresthesia, subjective skin sensations such as cold, heat, tingling, and pressure, while 73 suffered peripheral facial paralysis, 23 seizures, and 14 lost consciousness.
About 220 people had an allergic reaction after the first injection and 101 after the second, it could be itching or swelling of the upper respiratory tract. 4 received anaphylactic shock after the first dose and 3 after the second.
Read more:
Three new vaccines on the way to Sweden: “We got a wider width”
Companies compete to ship their vaccines to Israel first
